The U.S. Department of Health and Human Services (HHS) finalized the Health Data, Technology, and Interoperability: ONC Deregulatory Actions to Unleash Prosperity (HTI-5) Final Rule, which is projected to save more than $1.5 billion in regulatory costs.
The HTI-5 rule was finalized Monday by HHS’ Office of the National Coordinator for Health Information Technology (ONC), which oversees the federal health IT certification program. HHS said the changes are intended to reduce administrative burdens on health IT developers and support innovation.
Rule Targets Compliance Costs
The HTI-5 rule reduces administrative burdens for developers participating in the ONC Health IT Certification Program, freeing up resources for improving user experiences for patients and clinicians, according to the HHS.
HHS Secretary Robert Kennedy Jr. said American doctors and patients "need better technology, not more Washington paperwork." He added that the Trump administration is "eliminating unnecessary regulations that cost more than $1.5 billion and hold back innovation."
The administration says reducing these regulatory burdens will allow developers to focus more on building technology for healthcare providers and patients. Tom Keane, M.D., National Coordinator for Health IT, said the changes would lower developers’ administrative compliance burden
Electronic Health Record Changes
Electronic health records (EHRs) are digital systems hospitals use to manage patients’ medical information. The HTI-5 rule removes 14 of the 60 criteria used to certify EHR systems sold by companies such as Epic and Oracle Health, the healthcare technology business of Oracle Corp. (NYSE: ORCL), while substantially revising seven others, STAT News reported Monday.
The changes raised concerns about potential effects on the security and privacy of sensitive health information and efforts to ensure the safety of products that rely on artificial intelligence (AI), the report noted.
Oracle and Epic did not immediately respond to Benzinga’s requests for comment.
Oracle’s Health Products
Oracle also announced Oracle Health Oncology EHR in September, a new electronic health record system designed for cancer care. The system includes AI assistants, cancer-care timelines and tools to bring together genomic, imaging, pathology, laboratory and pharmacy data, the company said.
Price Action: Oracle shares fell 0.02% to close at $126.06 on Monday. In premarket trading Tuesday, the stock rose 1.14% to $127.50.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
